betaxolol has been researched along with Anemia, Hemolytic in 1 studies
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, S | 1 |
| Fukunaga, S | 1 |
| Tayama, E | 1 |
| Nakamura, E | 1 |
| Egawa, N | 1 |
| Hosokawa, Y | 1 |
1 other study available for betaxolol and Anemia, Hemolytic
| Article | Year |
|---|---|
Benefits of a beta-blocker for intractable hemolysis due to paraprosthetic leakage.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Anemia, Hemolytic; Aspartate Aminotransferases; B | 2007 |